S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
GRAPHITE: "Essential for America's National Defense" (Ad)
How to Find Penny Stocks to Invest and Trade
Can Cummins Power To A New High? 
The #1 Energy Stock to Buy (Ad)
What Tyson Foods Q1 Means For Staples Stocks
ONSemi Is Marching Higher On Great Results
Move Over Lithium – 220 Pounds of Graphite In Every EV Battery (Ad)
Here’s the Silver Lining with Snap Stock Earnings Collapse
Stocks slip as worries about high rates weigh on Wall Street
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
GRAPHITE: "Essential for America's National Defense" (Ad)
How to Find Penny Stocks to Invest and Trade
Can Cummins Power To A New High? 
The #1 Energy Stock to Buy (Ad)
What Tyson Foods Q1 Means For Staples Stocks
ONSemi Is Marching Higher On Great Results
Move Over Lithium – 220 Pounds of Graphite In Every EV Battery (Ad)
Here’s the Silver Lining with Snap Stock Earnings Collapse
Stocks slip as worries about high rates weigh on Wall Street
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
GRAPHITE: "Essential for America's National Defense" (Ad)
How to Find Penny Stocks to Invest and Trade
Can Cummins Power To A New High? 
The #1 Energy Stock to Buy (Ad)
What Tyson Foods Q1 Means For Staples Stocks
ONSemi Is Marching Higher On Great Results
Move Over Lithium – 220 Pounds of Graphite In Every EV Battery (Ad)
Here’s the Silver Lining with Snap Stock Earnings Collapse
Stocks slip as worries about high rates weigh on Wall Street
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
GRAPHITE: "Essential for America's National Defense" (Ad)
How to Find Penny Stocks to Invest and Trade
Can Cummins Power To A New High? 
The #1 Energy Stock to Buy (Ad)
What Tyson Foods Q1 Means For Staples Stocks
ONSemi Is Marching Higher On Great Results
Move Over Lithium – 220 Pounds of Graphite In Every EV Battery (Ad)
Here’s the Silver Lining with Snap Stock Earnings Collapse
Stocks slip as worries about high rates weigh on Wall Street
NASDAQ:DBVT

DBV Technologies - DBVT Stock Forecast, Price & News

$1.38
-0.02 (-1.43%)
(As of 02/6/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.34
$1.39
50-Day Range
$1.16
$1.58
52-Week Range
$1.08
$3.43
Volume
42,183 shs
Average Volume
174,089 shs
Market Capitalization
$259.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.63

DBV Technologies MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.60 Rating Score
Upside/​Downside
307.6% Upside
$5.63 Price Target
Short Interest
Bearish
1.01% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.00mentions of DBV Technologies in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.01) to ($0.88) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.46 out of 5 stars

Medical Sector

937th out of 1,027 stocks

Biological Products, Except Diagnostic Industry

155th out of 169 stocks

DBVT stock logo

About DBV Technologies (NASDAQ:DBVT) Stock

DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that includes ongoing clinical trials of Viaskin peanut, and Viaskin milk, as well as pre-clinical development of Viaskin egg. The company was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont, and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Montrouge, France.

Receive DBVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DBV Technologies and its competitors with MarketBeat's FREE daily newsletter.

DBVT Stock News Headlines

Is This Stock On Your Radar
This stock is positioned like its peers that cashed out.
DBV Technologies S.A. (DBVT)
A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
Dbv Technologies SA
See More Headlines
Receive DBVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DBV Technologies and its competitors with MarketBeat's FREE daily newsletter.

DBVT Company Calendar

Last Earnings
8/01/2021
Today
2/07/2023
Next Earnings (Estimated)
3/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:DBVT
Employees
92
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$5.63
High Stock Price Forecast
$10.00
Low Stock Price Forecast
$1.50
Forecasted Upside/Downside
+307.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.60
Research Coverage
5 Analysts

Profitability

Net Income
$-97,810,000.00
Net Margins
-778.60%
Pretax Margin
-777.38%

Debt

Sales & Book Value

Annual Sales
$5.71 million
Book Value
$0.90 per share

Miscellaneous

Free Float
187,144,000
Market Cap
$259.81 million
Optionable
Optionable
Beta
1.26

Key Executives

  • Daniel Tassé
    Chief Executive Officer & Executive Director
  • Sébastien Robitaille
    Chief Financial Officer
  • Pharis Mohideen
    Chief Medical Officer
  • Pascal Wotling
    Chief Technical Operations & Quality Officer
  • Pascale Ehouarn
    Chief Engineering, Manufacturing & Supply Officer













DBVT Stock - Frequently Asked Questions

Should I buy or sell DBV Technologies stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DBV Technologies in the last twelve months. There are currently 1 sell rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" DBVT shares.
View DBVT analyst ratings
or view top-rated stocks.

What is DBV Technologies' stock price forecast for 2023?

5 equities research analysts have issued 12-month price objectives for DBV Technologies' stock. Their DBVT share price forecasts range from $1.50 to $10.00. On average, they anticipate the company's stock price to reach $5.63 in the next year. This suggests a possible upside of 307.6% from the stock's current price.
View analysts price targets for DBVT
or view top-rated stocks among Wall Street analysts.

How have DBVT shares performed in 2023?

DBV Technologies' stock was trading at $1.53 on January 1st, 2023. Since then, DBVT shares have decreased by 9.8% and is now trading at $1.38.
View the best growth stocks for 2023 here
.

When is DBV Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 2nd 2023.
View our DBVT earnings forecast
.

How were DBV Technologies' earnings last quarter?

DBV Technologies S.A. (NASDAQ:DBVT) released its quarterly earnings data on Sunday, August, 1st. The company reported ($0.28) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.64) by $0.36. The business earned ($1.49) million during the quarter, compared to analysts' expectations of $3.53 million. DBV Technologies had a negative trailing twelve-month return on equity of 44.34% and a negative net margin of 778.60%.

What other stocks do shareholders of DBV Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DBV Technologies investors own include Aimmune Therapeutics (AIMT), OPKO Health (OPK), Bellicum Pharmaceuticals (BLCM), Axsome Therapeutics (AXSM), Gilead Sciences (GILD), Novavax (NVAX), AbbVie (ABBV), Pieris Pharmaceuticals (PIRS), Pfizer (PFE) and Sangamo Therapeutics (SGMO).

What is DBV Technologies' stock symbol?

DBV Technologies trades on the NASDAQ under the ticker symbol "DBVT."

Who are DBV Technologies' major shareholders?

DBV Technologies' stock is owned by a number of institutional and retail investors. Top institutional investors include Concourse Financial Group Securities Inc. (0.00%).

How do I buy shares of DBV Technologies?

Shares of DBVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is DBV Technologies' stock price today?

One share of DBVT stock can currently be purchased for approximately $1.38.

How much money does DBV Technologies make?

DBV Technologies (NASDAQ:DBVT) has a market capitalization of $259.81 million and generates $5.71 million in revenue each year. The company earns $-97,810,000.00 in net income (profit) each year or ($0.55) on an earnings per share basis.

How can I contact DBV Technologies?

DBV Technologies' mailing address is 177-181 AVENUE PIERRE BROSSOLETTE, MONTROUGE I0, 92120. The official website for the company is www.dbv-technologies.com. The company can be reached via phone at (315) 542-7878, via email at sara.sherman@dbv-technologies.com, or via fax at 33-1-43-26-10-83.

This page (NASDAQ:DBVT) was last updated on 2/7/2023 by MarketBeat.com Staff